Elizabeth Stillman is a knowledgeable and experienced Senior Scientist in biotechnology, with nine successful years of expertise in leading and contributing to IND-enabling pre-clinical research and clinical research. With a Ph.D. in Microbiology from the University of Tennessee-Health Science Center and post-doctoral research in Virology from the Stanford University School of Medicine, Elizabeth has a proven track record of designing, executing and managing research projects effortlessly. At Aragen Bioscience, Elizabeth serves as a Senior Research Scientist, where she has worked with live and subunit vaccine candidates, adjuvants, and composition sections for IND filing and assay development. Previously, Elizabeth worked at MedImmune as a Product Development Consultant, and as a Senior Research Scientist, where she honed her skills in vaccines and virology. An agile, enthusiastic, and personable researcher, Elizabeth's expertise in characterizing attributes of and immune responses makes her an invaluable asset to any team. She is a creative researcher who succeeds in tackling novel problems with undefined paths.